Results of docetaxel plus oxaliplatin (DOCOX) with or without cetuximab in patients with metastatic gastric and/or gastroesophagel junction adenocarcinoma: Results of a randomized phase II study.
D. A. Richards
No relevant relationships to disclose
D. M. Kocs
No relevant relationships to disclose
A. I. Spira
No relevant relationships to disclose
A. D. McCollum
No relevant relationships to disclose
K. A. Boehm
No relevant relationships to disclose
F. Zhan
No relevant relationships to disclose
L. Asmar
No relevant relationships to disclose